Walgreens Charity Classic November golf event to benefit three south Florida charities
Colgate introduces new Total Lasting White Mouthwash
NEW YORK — Colgate has expanded its mouthwash portfolio of products with the addition of the new Colgate Total Lasting White Mouthwash.
The new Colgate Total Lasting White Mouthwash has a fluoride formula that helps re-mineralize enamel, fights tartar and freshens breath without the burn of alcohol, the company stated. The new mouthwash also promises to create an invisible shield on teeth to help prevent stains from forming.
"Colgate has a long history of creating the most advanced products on store shelves today. We pride ourselves in listening to consumer wants and needs for products that allow them to maintain a healthy oral care routine while delivering a whitening benefit," stated Philip Durocher, VP and GM, U.S. Oral Care marketing, Colgate-Palmolive. "The addition of the Colgate Total Lasting White Mouthwash helps consumers achieve a healthy white smile that lasts."
Colgate Total Lasting White Mouthwash is available in Polar Freshmint and can be purchased at mass retailers nationwide.
Mylan launches capecitabine tabs
PITTSBURGH — Mylan announced the launch of capecitabine tablets USP in 150-mg and 500-mg dosage strengths. The drug is the generic version of Xeloda tablets from Genentech and is indicated as monotherapy, adjuvant therapy and combination therapy for certain types of breast, colon and colorectal cancers, according to the company.
"The approval of this product, one of a number of key approvals that had been pending with FDA, adds an important product to our broad and growing oncology franchise," said Heather Bresch, Mylan's CEO. "We look forward to bringing a lower cost generic version of this product to patients."
Capecitabine tablets had sales in the United States of approximately $773.8 million for the 12 months ending June 30, 2014, according to IMS Health data.